BRIEF-Nrx Pharmaceuticals Inc - Increases Maximum Aggregate Offering Price Under Aug 14 2023 ATM Agreement To $20 Million - SEC Filing

Reuters
18 Apr
BRIEF-Nrx Pharmaceuticals Inc - Increases Maximum Aggregate Offering Price Under Aug 14 2023 ATM Agreement To $20 Million - SEC Filing

April 17 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:

  • NRX PHARMACEUTICALS INC - INCREASES MAXIMUM AGGREGATE OFFERING PRICE UNDER AUG 14 2023 ATM AGREEMENT TO $20 MILLION - SEC FILING

Source text: [ID:n0001437749-25-012303]

Further company coverage: NRXP.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10